Novo Nordisk registers Phase 3 CagriSema hypertension trial; posts results for two other studiesNov 6Weekly roundup, 4 itemsCagrisemaNNC0487-0111Updated
Novo Nordisk adds four registrations: new molecule trial, CagriSema switch study, real-world dataOct 2Weekly roundup, 9 itemsCagrisemaNNC0705-0002Updated
Novo Nordisk registers Phase 3 obesity trial in Japan; new CagriSema switch studySep 16Weekly roundup, 2 itemsCagrisemaNNC0487-0111